Premium
Prognostic value of 18 F‐fluorodeoxyglucose positron emission tomography/computed tomography in patients with cutaneous angiosarcoma: A retrospective study of 18 cases
Author(s) -
Umemura Hiroshi,
Yamasaki Osamu,
Kaji Tatsuya,
Hamada Toshihisa,
Otsuka Masaki,
Asagoe Kenji,
Iwatsuki Keiji
Publication year - 2017
Publication title -
the journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.9
H-Index - 65
eISSN - 1346-8138
pISSN - 0385-2407
DOI - 10.1111/1346-8138.13839
Subject(s) - medicine , positron emission tomography , angiosarcoma , nuclear medicine , univariate analysis , fluorodeoxyglucose , retrospective cohort study , radiology , positron emission , sarcoma , standardized uptake value , multivariate analysis , surgery , pathology
Cutaneous angiosarcoma (CAS) is a rare soft tissue sarcoma with rapid growth and poor prognosis. We retrospectively analyzed the data of 18 patients with CAS who underwent 18 F‐Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) at the initial visit to the Department of Dermatology, Okayama University Hospital from September 2006 to March 2016. In the univariate survival analysis, patients with high standardized uptake values (SUV max ) of the primary tumor showed significantly poorer prognosis than those with low SUV max . Early assessment of prognosis using PET/CT may predict patient survival and is useful in the selection of therapeutic strategies.